wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55452513-188CD2C1-05A3-42FA-A27D-A96A1008A606
Q55452513-188CD2C1-05A3-42FA-A27D-A96A1008A606
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55452513-188CD2C1-05A3-42FA-A27D-A96A1008A606
Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na+/K+-ATPase activity and hypoxia-inducible pathways.
P2860
Q55452513-188CD2C1-05A3-42FA-A27D-A96A1008A606
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55452513-188CD2C1-05A3-42FA-A27D-A96A1008A606
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5935bfd7d56355e34b203d8bf7c1b8ac0a2cdf42
P2860
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial